Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 513

1.
2.
3.

Disruption of CD40/CD40L interaction influences the course of Cryptococcus neoformans infection.

Pietrella D, Lupo P, Perito S, Mosci P, Bistoni F, Vecchiarelli A.

FEMS Immunol Med Microbiol. 2004 Jan 15;40(1):63-70.

4.

Fas-FasL interactions modulate host defense against systemic Candida albicans infection.

Netea MG, van Der Meer JW, Meis JF, Kullberg BJ.

J Infect Dis. 1999 Nov;180(5):1648-55.

PMID:
10515828
5.

Gene targeting demonstrates that inducible nitric oxide synthase is not essential for resistance to oral candidiasis in mice, or for killing of Candida albicans by macrophages in vitro.

Farah CS, Saunus JM, Hu Y, Kazoullis A, Ashman RB.

Oral Microbiol Immunol. 2009 Feb;24(1):83-8. doi: 10.1111/j.1399-302X.2008.00462.x.

PMID:
19121076
6.

Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection.

Soong L, Xu JC, Grewal IS, Kima P, Sun J, Longley BJ Jr, Ruddle NH, McMahon-Pratt D, Flavell RA.

Immunity. 1996 Mar;4(3):263-73.

7.

The role of CD40L in T cell-dependent nitric oxide production by murine macrophages.

Bingaman AW, Pearson TC, Larsen CP.

Transpl Immunol. 2000 Nov;8(3):195-202.

PMID:
11147700
8.
9.

Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice.

Stout RD, Suttles J, Xu J, Grewal IS, Flavell RA.

J Immunol. 1996 Jan 1;156(1):8-11.

PMID:
8598498
10.

Endogenous interleukin (IL)-1 alpha and IL-1 beta are crucial for host defense against disseminated candidiasis.

Vonk AG, Netea MG, van Krieken JH, Iwakura Y, van der Meer JW, Kullberg BJ.

J Infect Dis. 2006 May 15;193(10):1419-26. Epub 2006 Apr 4.

PMID:
16619190
11.

Enhancement of tumoricidal activity of alveolar macrophages via CD40-CD40 ligand interaction.

Imaizumi K, Kawabe T, Ichiyama S, Kikutani H, Yagita H, Shimokata K, Hasegawa Y.

Am J Physiol. 1999 Jul;277(1 Pt 1):L49-57.

12.

The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis.

Netea MG, Van Der Graaf CA, Vonk AG, Verschueren I, Van Der Meer JW, Kullberg BJ.

J Infect Dis. 2002 May 15;185(10):1483-9. Epub 2002 Apr 30.

PMID:
11992285
13.

The CD40 ligand. At the center of the immune universe?

Grewal IS, Flavell RA.

Immunol Res. 1997 Feb;16(1):59-70. Review.

PMID:
9048208
14.

Differential role of IL-18 and IL-12 in the host defense against disseminated Candida albicans infection.

Netea MG, Vonk AG, van den Hoven M, Verschueren I, Joosten LA, van Krieken JH, van den Berg WB, Van der Meer JW, Kullberg BJ.

Eur J Immunol. 2003 Dec;33(12):3409-17.

15.
16.

Functional and in situ evidence for nitric oxide production driven by CD40-CD40L interactions in graft-versus-leukemia reactivity.

Müerköster S, Laman JD, Rocha M, Umansky V, Schirrmacher V.

Clin Cancer Res. 2000 May;6(5):1988-96.

17.
18.

A role for CD40-CD40 ligand interactions in the generation of type 1 cytokine responses in human leprosy.

Yamauchi PS, Bleharski JR, Uyemura K, Kim J, Sieling PA, Miller A, Brightbill H, Schlienger K, Rea TH, Modlin RL.

J Immunol. 2000 Aug 1;165(3):1506-12.

19.

Iron overload alters innate and T helper cell responses to Candida albicans in mice.

Mencacci A, Cenci E, Boelaert JR, Bucci P, Mosci P, Fè d'Ostiani C, Bistoni F, Romani L.

J Infect Dis. 1997 Jun;175(6):1467-76.

PMID:
9180188
20.

Differential requirements of T cell subsets for CD40 costimulation in immunity to Blastomyces dermatitidis.

Wüthrich M, Fisette PL, Filutowicz HI, Klein BS.

J Immunol. 2006 May 1;176(9):5538-47.

Supplemental Content

Support Center